You have 9 free searches left this month | for more free features.

Posaconazole

Showing 26 - 50 of 105

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neutropenia Trial (Posaconazole IV solution, Posaconazole powder for oral suspension)

Completed
  • Neutropenia
  • Posaconazole IV solution
  • Posaconazole powder for oral suspension
  • (no location specified)
May 28, 2019

Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

Not yet recruiting
  • Mature B-Cell Neoplasm
  • +25 more
  • (no location specified)
Sep 14, 2022

Myelodysplastic Syndrome Patients

Completed
  • Myelodysplastic Syndrome
  • Antibiotic and antifungal drugs
  • Alessandria, Italy
  • +24 more
Sep 6, 2021

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain Trial in Hershey (Ketoconazole)

Recruiting
  • Glioblastoma
  • +3 more
  • Hershey, Pennsylvania
    Penn State Milton S Hershey Medical Center
Jul 12, 2022

Leukemia, Myeloid, Acute Trial (HDM201, cytarabine, anthracycline)

Withdrawn
  • Leukemia, Myeloid, Acute
  • (no location specified)
Jan 6, 2020

Azole Resistance in A. Fumigatus to Improve Patient Outcome.

Completed
  • Aspergillosis, Invasive Pulmonary
  • PCR based detection of azole resistance in A. fumigatus
  • Amsterdam, Netherlands
  • +7 more
Mar 22, 2022

Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

Recruiting
  • Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • "3+7"
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 29, 2023

Leukemia, Fungal Infection Trial in Houston (Posaconazole)

Completed
  • Leukemia
  • Fungal Infection
  • Posaconazole
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 5, 2019

Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Completed
  • Relapsed Acute Myeloid Leukemia
  • +3 more
  • VAH regimen
  • VEN+HMA regimen
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 8, 2022

Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives

Recruiting
  • Critical Illness
  • +2 more
  • blood drug concentration
  • Harefield, Middlesex, United Kingdom
    Royal Brompton & Harefield NHS Foundation Trust
Dec 17, 2020

Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

Recruiting
  • Hypomethylating Agent
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023

Pharmacokinetics Trial in Dallas (Milademetan, Itraconazole, Posaconazole)

Completed
  • Pharmacokinetics
  • Dallas, Texas
    Covance Clinical Research Unit, Inc.
Feb 8, 2019

Invasive Fungal Infections Trial in Italy

Completed
  • Invasive Fungal Infections
    • Bologna, Italy
    • +13 more
    Oct 25, 2022

    Venetoclax Plasma Concentration and Remission in Acute Myeloid

    Not yet recruiting
    • Adult Acute Myeloid Leukemia
    • Blood sampling for venetoclax drug dosage (venous puncture)
    • (no location specified)
    Sep 13, 2023

    Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)

    Recruiting
    • Previously Untreated Acute Myeloid Leukemia
    • Samalizumab (BAML-16-001-S1)
    • +32 more
    • Phoenix, Arizona
    • +18 more
    Oct 17, 2022

    Respiratory Syncytial Virus Infections Trial in Worldwide (JNJ-53718678 250 mg, Placebo, JNJ-53718678 125 mg)

    Terminated
    • Respiratory Syncytial Virus Infections
    • JNJ-53718678 250 mg
    • +2 more
    • Los Angeles, California
    • +68 more
    Mar 3, 2022

    Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

    Not yet recruiting
    • Myeloid Malignancy
    • Acute Myeloid Leukemia
    • Cleveland, Ohio
      University Hospitals Seidman Cancer, Case Comprehensive Cancer C
    Nov 8, 2023

    CMV Viremia Trial (Letermovir Pill)

    Not yet recruiting
    • CMV Viremia
    • Letermovir Pill
    • (no location specified)
    Jun 20, 2022

    Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Leukemia, Lymphocytic, Acute
    • Houston, Texas
    • +5 more
    May 31, 2022

    Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    Febrile Neutropenia Trial (Early Discontinuation of Antibiotics, Standard of Care)

    Not yet recruiting
    • Febrile Neutropenia
    • Early Discontinuation of Antibiotics
    • Standard of Care
    • (no location specified)
    Mar 24, 2023

    Systemic Fungal Infections Trial (Posaconazole)

    Completed
    • Systemic Fungal Infections
    • Posaconazole
    • (no location specified)
    Aug 22, 2018

    Febrile Neutropenia Trial in Winston-Salem (Meropenem, Micafungin)

    Not yet recruiting
    • Febrile Neutropenia
    • Winston-Salem, North Carolina
      Wake Forest University Health Sciences
    Mar 13, 2023

    Invasive Fungal Infections in Patients Following Stem Cell

    Unknown status
    • Invasive Fungal Infections
    • Stem Cell Transplant Complications
    • No intervention
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Nov 4, 2020